Kiromic Biopharma, Inc.
KRBPDelisted Nov 20, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001792581
Kiromic Biopharma, Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Aug 26, 2024; no institution reported holding it in 13F filings for Q3 2023; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Kiromic Biopharma, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −2 vs. Q3 2021
- Shares held
- 2.50M
- +59.1K (+2.4%) vs. Q3 2021
- Total value
- $3.82M
- −$3.67M (−49.0%) vs. Q3 2021
- New holders
- 5
- 10 more added
- Sold out
- 7
- 1 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 5 | $6.13K |
| Q1 2023 | 7 | $78.2K |
| Q4 2022 | 12 | $145.5K |
| Q3 2022 | 16 | $90.3K |
| Q2 2022 | 17 | $200.0K |
| Q1 2022 | 20 | $1.73M |
| Q4 2021 | 21 | $3.82M |
| Q3 2021 | 23 | $7.49M |
| Q2 2021 | 16 | $11.9M |
| Q1 2021 | 13 | $3.34M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Kiromic Biopharma, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kepos Capital LP | 767,000 | $1.17M | 0.10% | 00.0% | Unchanged |
| Sabby Management, LLC | 625,000 | $956.0K | 0.24% | +146,878+30.7% | Added |
| Lynwood Capital Management Inc. | 372,500 | $570.0K | 0.55% | +372,500 | New |
| Vanguard Group Inc | 296,123 | $453.0K | 0.00% | +835+0.3% | Added |
| LPL Financial LLC | 84,400 | $129.0K | 0.00% | +31,600+59.8% | Added |
| Zeke Capital Advisors, LLC | 56,899 | $87.0K | 0.01% | 00.0% | Unchanged |
| Redmond Asset Management, LLC | 48,010 | $73.0K | 0.02% | +1,640+3.5% | Added |
| Citadel Advisors LLC | 43,318 | $66.0K | 0.00% | +16,635+62.3% | Added |
| Geode Capital Management, LLC | 40,962 | $62.0K | 0.00% | −10,766−20.8% | Reduced |
| BlackRock Inc. | 36,257 | $55.0K | 0.00% | +5,612+18.3% | Added |
| Warberg Asset Management LLC | 33,815 | $52.0K | 0.02% | +21,815+181.8% | Added |
| K.J. Harrison & Partners Inc | 26,233 | $40.0K | 0.01% | +9,231+54.3% | Added |
| Susquehanna International Group, LLP | 19,184 | $29.0K | 0.00% | +19,184 | New |
| State Street Corp | 16,686 | $26.0K | 0.00% | 00.0% | Unchanged |
| Shay Capital LLC | 17,300 | $26.0K | 0.01% | +5,300+44.2% | Added |
| WealthTrust Axiom LLC | 10,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,908 | $4.00K | 0.00% | +2,908 | New |
| Morgan Stanley | 1,201 | $2.00K | 0.00% | +1+0.1% | Added |
| Wells Fargo & Company | 38 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 12 | $0 | 0.00% | +12 | New |
| Royal Bank of Canada | 39 | $0 | 0.00% | +39 | New |
| 1492 Capital Management LLC | 0 | $0 | 0.00% | −434,408−100.0% | Sold out |
| Intellectus Partners, LLC | 0 | $0 | 0.00% | −98,850−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,453−100.0% | Sold out |
| Resources Investment Advisors, LLC. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −2,789−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −810−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −40−100.0% | Sold out |